Your session is about to expire
← Back to Search
Teriparatide 20 mcg daily for Femoral Fracture
Study Summary
This trial will examine whether the osteoporosis medication teriparatide can help accelerate fracture healing and prevent surgical intervention in patients with an incomplete atypical femur fracture.
- Femoral Fracture
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What have been the findings regarding the safety of Teriparatide 20 mcg daily thus far?
"There is some evidence for efficacy and multiple rounds of safety data, so our team at Power rated Teriparatide 20 mcg daily as a 3 on the safety scale."
Would patients who are over the age of 45 be applicable to enroll in this research project?
"This particular clinical trial only allows patients that are between the ages of 30 and 100 to enroll. If a patient is outside of that age bracket, there are 70 other trials for patients under 18 and 322 for patients over the age of 65."
Is this an innovative clinical trial?
"Research on Teriparatide 20 mcg daily began in 2013 with an initial clinical trial sponsored by Eli Lilly and Company. Since the first study, which included 34 participants, Teriparatide 20 mcg daily received Phase 3 drug approval in 2013. There are currently 13 live studies involving Teriparatide 20 mcg daily across 7 cities and 9 countries."
Who does this research include in its sample size?
"This study requires 34 participants, aged 30 to 100, who currently have fractures. The fractures must be classified as 'atraumatic or low trauma incomplete stress fractures', which means they were sustained with minimal force, such as a fall from standing height. Additionally, the fractures must be located on the femoral shaft from the distal lesser trochanter to the proximal supracondylar flare."
Has Teriparatide 20 mcg daily been rigorously tested in other research trials?
"There are currently 13 Teriparatide 20 mcg daily studies underway, 1 of which is in Phase 3. The great majority of these trials are based in Lexington, Kentucky, but there are a total of 40 clinical trial sites for this medication."
Are individuals still being sought for participation in this clinical trial?
"Although this particular trial is not recruiting patients at this time, it's possible to find other trials seeking participants on clinicaltrials.gov. According to the website, the most recent update for this trial was on September 28th, 2020."
Share this study with friends
Copy Link
Messenger